Weiss Multi-Strategy Advisers’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,607	Closed	-$20K	–	829
2021 Q4	$20K	Sell	10,607 -43	-0.4%	-$103	﹤0.01%	634
2021 Q3	$32K	Buy	10,650 +231	+2%	+$823	﹤0.01%	655
2021 Q2	$41K	Buy	10,419 +374	+4%	+$1.55K	﹤0.01%	656
2021 Q1	$51K	Sell	10,045 -6,744	-40%	-$35K	﹤0.01%	685
2020 Q4	$69K	Sell	16,789 -1,412	-8%	-$6.94K	﹤0.01%	665
2020 Q3	$88K	Buy	18,201 +201	+1%	+$1.1K	﹤0.01%	541
2020 Q2	$100K	Buy	18,000 +2,556	+17%	+$11.7K	﹤0.01%	524
2020 Q1	$51K	Sell	15,444 -556	-3%	-$2.93K	﹤0.01%	404
2019 Q4	$72K	Buy	16,000 +1,000	+7%	+$3.16K	﹤0.01%	578
2019 Q3	$62K	Buy	+15,000	New	+$54.2K	﹤0.01%	561

Other funds holding AGTC

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AGTC Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2022, closing a stake of 10,607 shares — an estimated $20K sold.

Weiss Multi-Strategy Advisers first reported a position in AGTC in Q3 2019 and held it in 10 quarters. The position peaked at $100K in Q2 2020. 53 funds tracked by Wall St. Rank hold AGTC as of Q1 2022.

Weiss Multi-Strategy Advisers reported no remaining Applied Genetic Technologies Corporation position as of Q1 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 10,607 Applied Genetic Technologies Corporation shares in Q1 2022, an estimated $20K.
Weiss Multi-Strategy Advisers first reported a position in Applied Genetic Technologies Corporation in Q3 2019 and held it in 10 quarters.
Weiss Multi-Strategy Advisers's Applied Genetic Technologies Corporation position peaked at $100K in Q2 2020.
53 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.